Robert E. Waltermire, Senior VP, Chief Pharma Development at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 884 shares at $273.41 ($242K) on 2025-01-17, disclosed to the SEC on 2025-01-17.
Open-market sale of $242k MDGL by Senior VP, Chief Pharma Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $273.41 | 442 | $121K | 50.0% |
| 2 | $273.41 | 442 | $121K | 50.0% |
| Total | $273.41 avg | 884 | $242K | 100% |
| Filing → |
| MDGL | SELL | 2025-01-27 | $35K | — | Filing → |
| MDGL | SELL | 2024-06-18 | $532K | — | Filing → |
| MDGL | SELL | 2024-06-14 | $570K | — | Filing → |